Van Voorhees Seth
- SEC CIK
- 0001284934
No open-market purchases or sales filed in the past year.
Current role at each company
- NRXP NRX Pharmaceuticals, Inc.CHIEF FINANCIAL OFFICERas of Dec 19, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Van Voorhees Seth as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2022 (view filing) | Dec 16 | 3 days | Van Voorhees SethCHIEF FINANCIAL OFFICER | PPurchaseCommon Stock, par value $0.001 per share | +30.0K | $1.10 | +$33.0K | +183.6%46.3K after | |
| Dec 19, 2022 (view filing) | Nov 25 | 24 days | Van Voorhees SethCHIEF FINANCIAL OFFICER | PPurchaseCommon Stock, par value $0.001 per share | +16.3K | $1.11 | +$18.2K | New position16.3K after | Amended3 lots |